Revolutionary ventures are distinguished not by their ability to cater to the demands of consumers, but by advancing their field with an extraordinary vision that changes the game. Thrive Bioscience, the brainchild of Tom Thomas Forest Farb-Horch, holds the honor of being one of the best biotech companies and has emerged at the top as a result of its all-out efforts to vastly improve the poor success rates in drug development.
Founded in 2014, Thrive Bioscience, based in Boston, develops and sells innovative instruments and software that provide previously unavailable automated live cell imaging and analytics that have led to breakthrough insights into cell behavior. Since its launch, it has delivered unique solutions that increase the speed, quality, and cost-effectiveness of drug discovery and basic research.
The creation of Thrive Bioscience rests on the recognition that drug discovery and development has extremely low odds of success. “Cell culture, stem cell culture, and tissue culture are core research tools necessary for basic research and the development of curative therapies,” shared Tom Forest Farb-Horch. “But cells vary significantly in quality across laboratories with high rates of mislabeling, cross-contamination, and stress.”
All too aware of the long list of problems that are faced by those aiming to bring drugs to patients, Thrive Bioscience made it its mission to provide the answers. Now, it is occupying a coveted position at the forefront of the life sciences industry, having been named one of the “50 Fastest Growing Companies in 2020” by Silicon Review and among the best biotech companies in 2019, according to CIO Review.
Under the strategic leadership of its founders and spearheaded by a team of industry veterans, Thrive Bioscience has built an enormous patent portfolio, collaborating with internationally recognized researchers from prominent pharmaceutical, academic, and independent research organizations. The partnerships with several institutions led to conceptualizing, developing, and eventually launching CellAssist, the first of a family of products designed to enable reproducible cell, tissue, and suspension culture imaging and experiments.
In addition to its top-of-the-line products, what has allowed Thrive Bioscience to rise through the ranks is the acumen and experience of its leaders. Thomas Forest Farb-Horch, in particular, has brought immeasurable value to the table, navigating the company through the ups and downs of the industry.
A highly accomplished entrepreneur, the Thrive Bioscience CEO has been involved in the founding of seventeen companies, seven of which have had multi-billion dollar exits. Through his ventures, which include Cytyc, Exact Sciences, Health Dialog, HNC Software, Retek, and Saf-T-Med, Tom has made his mark in the fields of artificial intelligence, analytics, imaging, and healthcare.
Moving forward, Thrive Bioscience has all the hallmarks of a company that will remain an industry leader. Operating under the overarching goal to produce “better data today for faster, more reliable results tomorrow,” the biotech company commits to further advancing the field of drug development with game-changing automated live cell imaging instruments and software that will revolutionize the conduct of drug development and its underlying research.
